Rita Deng is an associate in O’Melveny’s Beijing office. She focused her practice in the area of capital markets, especially in representing issuers and underwriters in IPOs. Rita has also experience in handling post-listing compliance and many other corporate matters.
ECM Transactions
- Beijing Luzhu Biotechnology Co., Ltd. in its US$43 million IPO and listing on the Hong Kong Stock Exchange
- Sipai Health Technology Co., Ltd. in its IPO and listing on the Hong Kong Stock Exchange
- Jenscare Scientific Co., Ltd. in its IPO and listing on the Hong Kong Stock Exchange
- Hygeia Healthcare Holdings Co., Limited in its US$286 million IPO and listing on the Hong Kong Stock Exchange
- Simcere Pharmaceutical Group Limited in its US$461 million IPO and listing on the Hong Kong Stock Exchange
- Netjoy Holdings Limited in its US$180 million IPO and listing on the Hong Kong Stock Exchange
- Comba Telecom Systems Holdings Limited in its HK$680 million top-up placing
- Modern Dental Group in its HK$660 million IPO and listing on the Hong Kong Stock Exchange
Post-listing Compliance
- Numerous representations on corporate governance and continuing obligations under the Hong Kong Listing Rules, including Fulum Group Holdings Limited, Sunny Optical Technology (Group) Company Ltd., and China Success Finance Group Holdings Limited
Mergers & Acquisitions
- Acotec Scientific in its approximately US$520 million voluntary partial offer by Boston Scientific
Languages
- Mandarin Chinese
- Cantonese
- English
Admissions
- Hong Kong
Education
- University of Hong Kong, BBA (Law); LL.B.; PCLL
Related Practices